Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade

Bjoern Chapuy, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Kirsty Wienand, Atanas Kamburov, Gabriel K. Griffin, Pei-Hsuan Chen, Ana Lako, Robert A. Redd, Claire M. Cote, Matthew D. Ducar, Aaron R. Thorner, Scott J. Rodig, Gad Getz, Margaret A. Shipp

Blood (2019) 134 (26): 2369–2382.

https://doi.org/10.1182/blood.2019002067

Published: 2019

Includes: Supplemental data

Journal Articles

Dose-Intensification in Early Unfavorable Hodgkin Lymphoma: Long-Term Follow up of the German Hodgkin Study Group (GHSG) HD14 Trial

Sarah Gillessen, MD, Annette Plütschow, Michael Fuchs, MD, Jana Markova, MD, Richard Greil, MD, Max S. Topp, MD, Julia Meissner, MD, Josée M Zijlstra, MD PhD, Dennis A. Eichenauer, Volker Diehl, MD, Peter Borchmann, MD PhD, Andreas Engert, MD, Bastian von Tresckow, MD

Blood (2019) 134 (Supplement_1): 129.

https://doi.org/10.1182/blood-2019-125249

Published: 2019

Journal Articles

Should a Bulky Mediastinal Mass ≥7cm in the Longest Dimension be Considered an Adverse Prognostic Factor in Patients with Advanced Hodgkin Lymphoma and Negative Interim PET/CT?

Eldad J Dann, MD, Rebeca Lopez-Alonso, Shunan Qi, Tania Mashiach, Michal Weiler-Sagie, Joachim Yahalom, MD

Blood (2019) 134 (Supplement_1): 4051.

https://doi.org/10.1182/blood-2019-122824

Published: 2019

Journal Articles

Thrombosis and Anticoagulation in Malignant Superior Vena Cava Syndrome

Avi Leader, MD, Shlomit Tamir, MD, Tal Friehmann, MD, Nir Livneh, Roy Ratzon, MD, Elizabeth Dudnik, MD, Alon Rozental, MD, Orly Hamburger-Avnery, MD, Baruch Brenner, MD, Pia Raanani, Hugo ten Cate, MD PhD, Galia Spectre, MD PhD

Blood (2017) 130 (Supplement 1): 3716.

https://doi.org/10.1182/blood.V130.Suppl_1.3716.3716

Published: 2017

Journal Articles

Determinants of Circulating Tumor DNA Levels across Lymphoma Histologic Subtypes

Blood (2017) 130 (Supplement 1): 4018.

https://doi.org/10.1182/blood.V130.Suppl_1.4018.4018

Published: 2017

Journal Articles

End-of-Treatment CT and Serial FDG-PET Imaging to Assess Residual Disease in Primary Mediastinal B-Cell Lymphoma

Christopher Melani, MD, Ranjana H. Advani, MD, Mark Roschewski, MD, Kelsey M. Walters, BS, Clara C. Chen, MD, Lucia Barrato, MD, Mark A. Ahlman, MD, Milos D. Miljkovic, MD, Seth M. Steinberg, PhD, Margaret Shovlin, RN, Kieron Dunleavy, MD, Stefania Pittaluga, MD PhD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD PhD

Blood (2017) 130 (Supplement 1): 2859.

https://doi.org/10.1182/blood.V130.Suppl_1.2859.2859

Published: 2017

Journal Articles

Extramediastinal Lesion in Patients with Primary Mediastinal Large B-Cell Lymphoma

Yana K. Mangasarova, MD PhD, Aminat U. Magomedova, MD PhD, Alla M. Kovrigina, MD PhD, Anna E. Misyurina, PhD MD, Ekaterina S. Nesterova, MD PhD, Sergey K. Kravchenko, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5232.

https://doi.org/10.1182/blood.V130.Suppl_1.5232.5232

Published: 2017

Journal Articles

Therapeutic Results in Patients with Hodgkin's Lymphoma Treated with Brentuximab Vedotin — Bulgarian Experience

Veselina S Goranova Marinova, MD PhD, Kalina Ignatova, MD, Penka Ganeva, MD, Emil Spasov, MD PhD, Ilina Micheva, MD PhD, Atanas Radinov, MD, Raya Petrova, MD, Gergana Tzvetkova, MD, Eugueni Hadzhiev, MD PhD, Stefan E Goranov, MD PhD DMSc, Liana Gercheva, MD PhD

Blood (2017) 130 (Supplement 1): 5193.

https://doi.org/10.1182/blood.V130.Suppl_1.5193.5193

Published: 2017

Journal Articles

Bone Marrow Involvement in Primary Mediastinal B-Cell Large-Cell Lymphoma

Ekaterina Alexsandrovna Fastova, Aminat U. Magomedova, MD PhD, Alla M. Kovrigina, MD PhD, Yana K. Mangasarova, MD PhD, Sergey K. Kravchenko, MD PhD, Valeriy G. Savchenko, Andrey I. Vorobiev

Blood (2017) 130 (Supplement 1): 5239.

https://doi.org/10.1182/blood.V130.Suppl_1.5239.5239

Published: 2017

Journal Articles

DA-EPOCH-R in Primary Mediastinal B-Cell Lymphoma; Analysis of End of Therapy FDG-PET and Outcome

Christopher Joseph Melani, MD, Ranjana Advani, MD, Clara C. Chen, MD, Kelsey M. Walters, BS, David Venzon, PhD, Seth M. Steinberg, PhD, Margaret Shovlin, RN, Elaine S. Jaffe, MD, Stefania Pittaluga, MD PhD, Mark Roschewski, MD, Wyndham H. Wilson, MD PhD, Kieron Dunleavy, MD

Blood (2016) 128 (22): 1116.

https://doi.org/10.1182/blood.V128.22.1116.1116

Published: 2016

Journal Articles

Favorable Outcome in a Large Cohort of Prospectively Treated Adult Patients with T-Lymphoblastic Lymphoma (T-LBL) Despite Slowly Evolving Complete Remission Assessed By Conventional Radiography

Nicola Gökbuget, MD, Andrea Wolf, Matthias Stelljes, MD, Andreas Hüttmann, MD, Eike C. Buss, Andreas Viardot, Kalina Brandt, MD, Maike de Wit, MD, Norbert Frickhofen, MD, Maxim Kebenko, MD, Mustafa Kondakci, MD, Doris Kraemer, MD, Stefan Schwartz, MD, Hubert Serve, MD, Karsten Spiekermann, MD, Reingard Stuhlmann, MD, Albrecht Reichle, Dieter Hoelzer, MD

Blood (2014) 124 (21): 370.

https://doi.org/10.1182/blood.V124.21.370.370

Published: 2014

Journal Articles

Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study

Eldad J Dann, MD, Osnat Bairey, MD, Rachel Bar-Shalom, MD, Elinor Sabbag, BSc., Marina Izak, MD, Abraham Korenberg, MD, Luiza Akria, MD, Dina Attias, MD, Kalman Filanovsky, MD, Uri Abadi, MD, Rosa Ruchlemer, MD, Roxolyana Abdah-Bortnyak, MD, Neta Goldschmidt, MD, Ron Epelbaum, MD, Netanel Horowitz, David Lavie, MD, Dina Ben Yehuda, MD, Ofer Shpilberg, MD, Ora B. Paltiel, MDM, MSc

Blood (2014) 124 (21): 4409.

https://doi.org/10.1182/blood.V124.21.4409.4409

Published: 2014

Journal Articles

Proposal of a Genetic Classifier for Risk Group Stratification in Pediatric T-Cell Lymphoblastic Lymphoma Reveals Significant Differences to T-Cell Lymphoblastic Leukemia

Bettina R. Bonn, Martin Zimmermann, PhD, Sebastian Balbach, Marius Rohde, Ilske Oschlies, Wolfram Klapper, MD, Olga Makarova, Claudia Rossig, MD, Birgit Burkhardt

Blood (2014) 124 (21): 2398.

https://doi.org/10.1182/blood.V124.21.2398.2398

Published: 2014

Journal Articles

A prospective study of mediastinal gray-zone lymphoma

Wyndham H. Wilson, Stefania Pittaluga, Alina Nicolae, Kevin Camphausen, Margaret Shovlin, Seth M. Steinberg, Mark Roschewski, Louis M. Staudt, Elaine S. Jaffe, Kieron Dunleavy

Blood (2014) 124 (10): 1563–1569.

https://doi.org/10.1182/blood-2014-03-564906

Published: 2014

Journal Articles

Clinical Features, Treatment Outcomes and Prognosis of Lymphoblastic Lymphoma: A Report On 52 Patients From a Single Center in China

Honghua Li, Yu Zhao, Wenrong Huang, Jian Bo, Shuhong Wang, Yu Jing, Chunji Gao, MD, Li Yu

Blood (2012) 120 (21): 4556.

https://doi.org/10.1182/blood.V120.21.4556.4556

Published: 2012

Journal Articles

Substantially Improved Outcome of Adult Burkitt Non-Hodgkin Lymphoma and Leukemia Patients with Rituximab and a Short-Intensive Chemotherapy; Report of a Large Prospective Multicenter Trial

Blood (2012) 120 (21): 667.

https://doi.org/10.1182/blood.V120.21.667.667

Published: 2012

Journal Articles

Gelatinous transformation

Claudiu V. Cotta

Blood (2012) 120 (11): 2166.

https://doi.org/10.1182/blood-2012-02-408815

Published: 2012

Journal Articles

FDG-PET and Hodgkin Lymphoma: Are We Ready for a Functional Tumor Volume Definition?

Francesco Merli, MD, Stefano Luminari, MD, Chiara Coriani, MD, Paolo G Gobbi, Prof, Federica Fioroni, Dr, Isabella Capodanno, MD, Alessandro Fraternali, MD, Caterina Mammi, PhD, Annibale Versari, MD

Blood (2011) 118 (21): 5187.

https://doi.org/10.1182/blood.V118.21.5187.5187

Published: 2011

Journal Articles

Excellent Results In the Treatment of Primary Mediastinal Lymphomas

Tamas Schneider, Zsuzsanna Molnar, Erika Toth, Jozsef Lovey, Erika Szaleczky, Erika Varady, Beata Deak, Fatima Varga, Sandor Fekete, MD, Andras Rosta

Blood (2010) 116 (21): 4915.

https://doi.org/10.1182/blood.V116.21.4915.4915

Published: 2010

Journal Articles

Liposomal Cytarabine (DepoCyte) Is Effective and Well Tolerated In Prophylaxis of Central Nervous System (CNS) Relapse of High Risk Lymphoma Patients

Wojciech Jurczak, Justyna Dzietczenia, Beata Piatkowska-Jakubas, Marcin Sobocinski, Tomasz Ogorka, Agnieszka Giza, Grzegorz Mazur, Tomasz Wrobel, MD, PhD, Aleksander Skotnicki, MD, PhD

Blood (2010) 116 (21): 4890.

https://doi.org/10.1182/blood.V116.21.4890.4890

Published: 2010

NARROW

Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade

Dose-Intensification in Early Unfavorable Hodgkin Lymphoma: Long-Term Follow up of the German Hodgkin Study Group (GHSG) HD14 Trial

Should a Bulky Mediastinal Mass ≥7cm in the Longest Dimension be Considered an Adverse Prognostic Factor in Patients with Advanced Hodgkin Lymphoma and Negative Interim PET/CT?

Thrombosis and Anticoagulation in Malignant Superior Vena Cava Syndrome

Determinants of Circulating Tumor DNA Levels across Lymphoma Histologic Subtypes

End-of-Treatment CT and Serial FDG-PET Imaging to Assess Residual Disease in Primary Mediastinal B-Cell Lymphoma

Extramediastinal Lesion in Patients with Primary Mediastinal Large B-Cell Lymphoma

Therapeutic Results in Patients with Hodgkin's Lymphoma Treated with Brentuximab Vedotin — Bulgarian Experience

Bone Marrow Involvement in Primary Mediastinal B-Cell Large-Cell Lymphoma

DA-EPOCH-R in Primary Mediastinal B-Cell Lymphoma; Analysis of End of Therapy FDG-PET and Outcome

Favorable Outcome in a Large Cohort of Prospectively Treated Adult Patients with T-Lymphoblastic Lymphoma (T-LBL) Despite Slowly Evolving Complete Remission Assessed By Conventional Radiography

Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study

Proposal of a Genetic Classifier for Risk Group Stratification in Pediatric T-Cell Lymphoblastic Lymphoma Reveals Significant Differences to T-Cell Lymphoblastic Leukemia

A prospective study of mediastinal gray-zone lymphoma

Clinical Features, Treatment Outcomes and Prognosis of Lymphoblastic Lymphoma: A Report On 52 Patients From a Single Center in China

Substantially Improved Outcome of Adult Burkitt Non-Hodgkin Lymphoma and Leukemia Patients with Rituximab and a Short-Intensive Chemotherapy; Report of a Large Prospective Multicenter Trial

Gelatinous transformation

FDG-PET and Hodgkin Lymphoma: Are We Ready for a Functional Tumor Volume Definition?

Excellent Results In the Treatment of Primary Mediastinal Lymphomas

Liposomal Cytarabine (DepoCyte) Is Effective and Well Tolerated In Prophylaxis of Central Nervous System (CNS) Relapse of High Risk Lymphoma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only